What insurance typically covers FDA-approved peptides for approved indications: Semaglutide (Ozempic) for type 2 diabetes: Often covered Semaglutide (Wegovy) for obesity: Sometimes covered with restrictions Tirzepatide (Mounjaro) for type 2 diabetes: Often covered Tirzepatide (Zepbound) for obesity: Limited coverage What coverage looks like: Prior authorization typically required Documentation of failed dietary interventions BMI thresholds for weight loss indications Co-pays still substantial ($100-500 monthly) What insurance doesn't cover The vast majority of peptide therapy falls outside insurance coverage: Compounded peptides (BPC-157, TB-500, most growth hormone peptides) Anti-aging applications even for FDA-approved drugs Performance enhancement uses Off-label applications These costs are entirely out-of-pocket for most patients
Each of these points reflects findings from the experimental literature rather than approved indications
Given the high curing potential, very safe profile (lethal dose not achieved), and with a suitably wide effective range (g-ng regimens) and unlimited methods of application (i.e., intraperitoneal, intragastric, in drinking water or topically, at the site of injury) (for review, see [1,3,4,5,6,8,9,32,33,34])), it may be a real challenge for further therapy
POWERFUL NATURAL INGREDIENTS FOR JOINT HEALTH: ArthroFlex Advanced delivers a high-quality joint health supplement featuring native type II collagen, turmeric curcumin, and boswellia extract
It also supports the creation of red blood cells, which prevents anaemia and ensures our body gets enough oxygen